1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-151876
    Glucocorticoid receptor modulator 1 Inhibitor 99.79%
    Glucocorticoid receptor modulator 1 是一种高效且具有口服活性的 NF-κBAP-1 抑制剂,IC50 分别为 9 nM 和 130 nM。Glucocorticoid receptor modulator 1 可有效降低炎症因子 IL-6、IL-1β、TNF-α 的表达,可缓解小鼠皮炎。
    Glucocorticoid receptor modulator 1
  • HY-N6065
    Praeruptorin A

    白花前胡甲素

    99.57%
    Praeruptorin A 是白花前胡 (Peucedanum praeruptorum) 的一种主要生物活性成分。Praeruptorin A 通过抑制 NF-κB 活化而发挥抗炎作用。
    Praeruptorin A
  • HY-P99579
    Tamtuvetmab

    坦妥维单抗

    Inhibitor
    Tamtuvetmab (AT-005) 是一种抗 CD52 的犬用金色单抗。Tamtuvetmab 可增加无进展生存期 (PFS),对患有稚嫩 T 细胞淋巴瘤 (LSA) 犬表现出疗效。Tamtuvetmab 已被兽医批准。
    Tamtuvetmab
  • HY-N11768
    4-Methoxylonchocarpin Inhibitor ≥98.0%
    4-Methoxylonchocarpin 是一种口服有效的抗炎剂。4-Methoxylonchocarpin 抑制 LPS 与 Toll 样受体 4 (TLR4) 的结合来抑制 NF-κB 活化以及肿瘤坏死因子 (TNF) 和白细胞介素 IL-6 的表达。4-Methoxylonchocarpin 还抑制 TGF-beta 激活激酶 1 的磷酸化和 2,4,6-三硝基苯磺酸 (TNBS) 诱导的 IL-1β、IL-17A 和 TNF 表达。4-Methoxylonchocarpin 能改善 TNBS 诱导的结肠炎小鼠模型。
    4-Methoxylonchocarpin
  • HY-N8284
    Tomentosin Inhibitor 98.95%
    Tomentosin 是一种具有口服活性的天然倍半萜内酯。Tomentosin 具有抗肿瘤、抗真菌、抗炎抗氧化和神经保护等多种活性。Tomentosin 可抑制肿瘤细胞增殖、迁移和侵袭,并诱导细胞凋亡 (apoptosis)。Tomentosin 可用于肿瘤、炎症和神经系统疾病的研究。
    Tomentosin
  • HY-N1022
    11-Hydroxytephrosin Inhibitor ≥98.0%
    11-Hydroxytephrosin 是一种有效的 NF-kappaB 抑制剂。已知 NF-kappaB 在调节控制免疫系统、细胞凋亡 (apoptosis)、肿瘤细胞生长和组织分化的基因中发挥关键作用。
    11-Hydroxytephrosin
  • HY-173414
    PROTAC STING degrader-3 Inhibitor
    PROTAC STING degrader-3 (Compound ST9) 是一种 STING PROTAC 类降解剂 (DC50: 0.62 μM)。PROTAC STING degrader-3 通过泛素-蛋白酶体途径诱导 STING 降解。PROTAC STING degrader-3 通过抑制 STING/TBK1/NF-κB 信号传导发挥抗炎作用。PROTAC STING degrader-3 具有肾脏保护作用,可用于急性肾损伤的研究 (粉色: STING 配体 (HY-47709); 蓝色: E3 连接酶 CRBN 配体 (HY-41547); 黑色: 连接子)。
    PROTAC STING degrader-3
  • HY-123503
    Salicortin

    特里杨甙

    Inhibitor
    Salicortin 是一种酚类糖苷,已从许多植物 (如胡杨和柳属植物) 中分离出来。Salicortin 通过下调 JNKNF-κB/NFATc1 信号通路抑制破骨细胞分化和骨吸收。Salicortin 具有抗遗忘,抗脂肪形成和免疫调节活性。
    Salicortin
  • HY-P5275
    Tripeptide-41 Inducer 99.63%
    Tripeptide-41(CG-Lipoxyn) 是一种具有减少脂肪堆积作用的生物活性肽,已被报道用作化妆品成分。
    Tripeptide-41
  • HY-173063
    TLR8 antagonist-1 Inhibitor
    TLR8 antagonist-1 (Compound 10) 是一种选择性 TLR8 拮抗剂。TLR8 antagonist-1 可抑制 TLR8 介导的炎症和信号通路,减少 MyD88 募集以及抑制 NF-κBIRF 通路。TLR8 antagonist-1 具有抗炎的活性。
    TLR8 antagonist-1
  • HY-N4327
    Eurycomalactone

    东革内酯

    Inhibitor 98.99%
    Eurycomalactone 是一种可以从 Eurycoma longifolia Jack 中分离得到的活性拟松类化合物。Eurycomalactone 是一种有效的NF-κB 抑制剂,其 IC50 值为 0.5 μM。Eurycomalactone 可抑制蛋白合成,降低 cyclin D1 蛋白水平。Eurycomalactone 通过阻滞细胞周期于G2/M 期和延迟 DNA 双链断裂修复来提高放射敏感性。Eurycomalactone 抑制 AKT/NF-κB 信号通路的激活,诱导细胞凋亡并增强对 Cisplatin (HY-17394) 的化疗敏感性。
    Eurycomalactone
  • HY-B0185G
    Lidocaine (GMP) Inhibitor
    Lidocaine (GMP) 是 GMP 级别的 Lidocaine (HY-B0185)。GMP 级别的小分子可用做细胞疗法中的辅助试剂。Lidocaine 抑制涉及复杂电压和依赖性的钠通道 (sodium channels)。Lidocaine 通过调节 miR-145 表达和进一步抑制 MEK/ERKNF-κB 信号通路来减少胃癌细胞的生长,迁移和侵袭。Lidocaine 是一种酰胺衍生物,可用于研究室性心律失常。
    Lidocaine (GMP)
  • HY-N8413
    Chlojaponilactone B Inhibitor ≥98.0%
    Chlojaponilactone B 是一种具有抗炎特性的茚烷型倍半萜类化合物。Chlojaponilactone B 通过抑制 TLR4 并随后减少活性氧 (ROS) 的产生、下调 NF-κB 来抑制炎症反应,从而减少促炎细胞因子 iNOS、NO、COX-2、IL-6 和 TNF-α 的表达。
    Chlojaponilactone B
  • HY-107665
    Ro 106-9920 Inhibitor ≥99.0%
    Ro 106-9920 是一种有效的 NF-kappaB 抑制剂。Ro 106-9920 具有研究肿瘤和癌症疾病的潜力。
    Ro 106-9920
  • HY-162510
    SPDZi1 Inhibitor
    SPDZi1 是一种强效且选择性的 syntenin 抑制剂,可与 syntenin 的 PDZ1PDZ2 域结合。SPDZi1 与 syntenin PDZ 串联 (STNPDZ) 结合,Kd 为 3.6 μM。SPDZi1 抑制胶质母细胞瘤并降低 NF-κB(syntenin 的下游效应物)的活性。
    SPDZi1
  • HY-N1365R
    Isoscopoletin (Standard)

    异东莨菪素 (Standard)

    Inhibitor
    Isoscopoletin (Standard) 是 Isoscopoletin 的分析标准品。本产品用于研究及分析应用。Isoscopoletin (6-Hydroxy-7-methoxycoumarin) 是艾叶中的一种活性成分。 Isoscopoletin 具有显著的细胞增殖抑制作用,对人类 CCRF-CEM 白血病细胞和耐药亚系 CEM/ADR5000 作用的 IC50 值分别为 4.0 μM 和 1.6 μM。Isoscopoletin (6-Hydroxy-7-methoxycoumarin) 具有抑制 HBV 复制的活性。Isoscopoletin 通过抑制 MAPK/NF-κB/STAT/AKT 信号通路发挥抗氧化活性。
    Isoscopoletin (Standard)
  • HY-B0320AR
    Cromolyn disodium (Standard)

    色甘酸钠 (标准品)

    Inhibitor
    Cromolyn disodium (Standard) (Cromoglycate disodium (Standard)) 是 Cromolyn disodium (HY-B0320A) 的分析标准品。本产品用于研究及分析应用。 Cromolyn (Cromoglycate) disodium 是一种口服有效的 GSK-3β 抑制剂,IC50 为 2.0 μM。Cromolyn disodium 也是一种肥大细胞稳定剂,能抑制肥大细胞释放介质、调节反射性支气管收缩和降低非特异性支气管高反应性,可用支气管哮喘的研究。此外,Cromolyn disodium 还具有抗炎、抗过敏、抗组胺、抗肿瘤和神经保护等多种活性。
    Cromolyn disodium (Standard)
  • HY-135702
    UBS109 Inhibitor 99.20%
    UBS109 作为一种姜黄素类似物,具有促进成骨细胞的分化和矿化作用。UBS109 通过激活 Smad 和抑制 NF-kB 展现出对骨细胞功能的调节作用。UBS109 可用于骨组织工程和骨质疏松症研究中。
    UBS109
  • HY-N3979
    Grossamide

    克罗酰胺

    Inhibitor ≥98.0%
    Grossamide 是一种能从 Cannabis sativa L. 的干果中分离出的天然产物。Grossamide 具有抗神经炎症作用。
    Grossamide
  • HY-155765
    Anti-inflammatory agent 51 Inhibitor 98.08%
    Anti-inflammatory agent 51 (compound 11d) 是一种酰胺/磺酰胺衍生物,具有抗炎活性。Anti-inflammatory agent 51 抑制 NF-κB 激活,具有用于急性肺损伤和溃疡性结肠炎研究的潜力。
    Anti-inflammatory agent 51
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.